Retatrutide · 2023 Oct 26
Triple-Hormone-Receptor Agonist Retatrutide for Obesity. Reply.
Letter, Comment
Open attributed record →PubMed-attributed venue
The New England journal of medicine
8 selected PubMed bibliographic records attributed to The New England journal of medicine. Venue attribution is reproduced from PubMed and does not imply endorsement, editorial affiliation, article quality, or scientific validity.
Bibliographic records
8 selected records.
Peptide profiles
4 connected profiles.
Publication years
4 attributed years.
Attributed bibliography
Selected records
Retatrutide · 2023 Oct 26
Triple-Hormone-Receptor Agonist Retatrutide for Obesity.
Letter, Comment
Open attributed record →Retatrutide · 2023 Oct 26
Triple-Hormone-Receptor Agonist Retatrutide for Obesity.
Letter, Comment
Open attributed record →Liraglutide · 2019 04 28
Liraglutide in Children and Adolescents with Type 2 Diabetes.
Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
Open attributed record →Lixisenatide · 2016 Mar 17
Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome.
Letter, Comment
Open attributed record →Lixisenatide · 2016 Mar 17
Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome.
Letter, Comment
Open attributed record →Lixisenatide · 2016 Mar 17
Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome.
Letter, Comment
Open attributed record →Glucagon · 1973 Jan 04
Glucagon and obesity.
Journal Article
Open attributed record →